[1]
|
Ostrom, Q.T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N.E., Kruchko, C. and Barnholtz-Sloan, J.S. (2013) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010. Neuro-Oncology, 15, ii1-ii56. https://doi.org/10.1093/neuonc/not151
|
[2]
|
Louis, D.N., Perry, A., Reifen-berger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W.K., Ohgaki, H., Wiestler, O.D., Kleihues, P. and Ellison, D.W. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary. Acta Neu-ropathologica, 131, 803-820.
https://doi.org/10.1007/s00401-016-1545-1
|
[3]
|
Kumar A.A. and Abraham Koshy, A. (2017) Regression of Recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the Literature. World Neurosurgery, 108, 990.e11-990.e16.
https://doi.org/10.1016/j.wneu.2017.08.136
|
[4]
|
Barnholtz-Sloan, J.S., Ostrom, Q.T. and Cote, D. (2018) Epidemiology of Brain Tumors. Neurologic Clinics, 36, 395-419. https://doi.org/10.1016/j.ncl.2018.04.001
|
[5]
|
Tan, A.C., Ashley, D.M., López, G.Y., Malinzak, M., Friedman, H.S. and Khasraw, M. (2020) Management of Glioblastoma: State of the Art and Future Directions. CA: A Cancer Journal for Clinicians, 70, 299-312.
https://doi.org/10.3322/caac.21613
|
[6]
|
Weller, M., Felsberg, J., Hartmann, C., Berger, H., Steinbach, J.P., Schramm, J., Westphal, M., Schackert, G., Simon, M., Tonn, J.C., Heese, O., Krex, D., Nikkhah, G., Pietsch, T., Wiestler, O., Reifenberger, G., von Deimling, A. and Loeffler, M. (2009) Molecular Predictors of Progression-Free and Overall Survival in Patients with Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network. Journal of Clinical On-cology, 27, 5743-5750. https://doi.org/10.1200/JCO.2009.23.0805
|
[7]
|
Jiang, H., Zhu, Q., Wang, X., Li, M., Shen, S., Yang, C., Zhao, X., Li, M., Ma, G., Zhao, X., Chen, X., Yang, J. and Lin, S. (2023) Characterization and Clinical Implications of Different Malignant Transformation Patterns in Diffuse Low-Grade Gliomas. Cancer Science, 114, 3708-3718. https://doi.org/10.1111/cas.15889
|
[8]
|
Teng, C., Zhu, Y., Li, Y., Dai, L., Pan, Z., Wanggou, S. and Li, X. (2022) Recur-rence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy. Frontiers in Immunology, 13, Article ID: 899710. https://doi.org/10.3389/fimmu.2022.899710
|
[9]
|
Mazroui, Y., Mathou-lin-Pélissier, S., Macgrogan, G., Brouste, V. and Rondeau, V. (2013) Multivariate Frailty Models for Two Types of Recurrent Events with a Dependent Terminal Event: Application to Breast Cancer Data. Biometrical Journal, 55, 866-884. https://doi.org/10.1002/bimj.201200196
|
[10]
|
Pasin, O., Dirican, A., Ankarali, H., Disci, R. and Karanlik, H. (2020) As-sessment of Death Risk of Breast Cancer Patients with Joint Frailty Models. Saudi Medical Journal, 41, 491-498. https://doi.org/10.15537/smj.2020.5.25065
|
[11]
|
Rahman, F. and Begum, M. (2018) Survival Analysis of Recurrent Events on Prostate Cancer: Facts from Cancer Genome. Journal of Statistical Research, 51, 145-164. https://doi.org/10.47302/jsr.2017510204
|
[12]
|
Talebi-Ghane, E., Baghestani, A., Zayeri, F., Rondeau, V. and Akhavan, A. (2021) Joint Frailty Model for Recurrent Events and Death in Presence of Cure Fraction: Application to Breast Cancer Data. Biometrical Journal, 63, 725-744.
https://doi.org/10.1002/bimj.201900113
|
[13]
|
Charles-Nelson, A., Katsahian, S. and Schramm, C. (2019) How to Analyze and Interpret Recurrent Events Data in the Presence of a Terminal Event: An Application on Readmission after Colorectal Cancer Surgery. Statistics in Medicine, 38, 3476-3502. https://doi.org/10.1002/sim.8168
|
[14]
|
Li, G., Wu, F., Zeng, F., Zhai, Y., Feng, Y., Chang, Y., Wang, D., Jiang, T. and Zhang, W. (2021) A Novel DNA Repair-Related Nomogram Predicts Survival in Low-Grade Gliomas. CNS Neuroscience & Therapeutics, 27, 186-195.
https://doi.org/10.1111/cns.13464
|
[15]
|
Du, P., Chen, H., Lv, K. and Geng, D. (2022) A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas. Journal of Clinical Medicine, 11, Article 3802. https://doi.org/10.3390/jcm11133802
|
[16]
|
Wei, R., Zhao, C., Li, J., Yang, F., Xue, Y. and Wei, X. (2022) Online Calcu-lator to Predict Early Mortality in Patient with Surgically Treated Recurrent Lower-Grade Glioma. BMC Cancer, 22, Article No. 114.
https://doi.org/10.1186/s12885-022-09225-9
|
[17]
|
Wang, T., Zhu, C., Zheng, S., Liao, Z., Chen, B., Liao, K., Yang, X., Zhou, Z., Bai, Y., Wang, Z., Hou, Y., Qiu, Y. and Huang, R. (2021) A Novel Nomogram for Predicting the Risk of Short-Term Recurrence After Surgery in Glioma Patients. Frontiers in Oncology, 11, Article ID: 740413. https://doi.org/10.3389/fonc.2021.740413
|
[18]
|
Rondeau, V., Mathoulin-Pelissier, S., Jacqmin-Gadda, H., Brouste, V. and Soubeyran, P. (2007) Joint Frailty Models for Recurring Events and Death Using Maximum Penalized Likelihood Estimation: Application on Cancer Events. Biostatistics, 8, 708-721. https://doi.org/10.1093/biostatistics/kxl043
|
[19]
|
Ishwaran, H., Kogalur, U.B., Blackstone, E.H. and Lauer, M.S. (2008) Random Survival Forests. Annals of Applied Statistics, 2, 841-860. https://doi.org/10.1214/08-AOAS169
|
[20]
|
Collins, G.S., Reitsma, J.B., Altman, D.G. and Moons, K.G.M. (2015) Trans-parent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD State-ment. BMJ, 350, g7594.
https://doi.org/10.1136/bmj.g7594
|
[21]
|
Zhang, M., Wang, X., Chen, X., Zhang, Q. and Hong, J. (2020) Novel Im-mune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma. Frontiers in Genetics, 11, Article 363.
https://doi.org/10.3389/fgene.2020.00363
|
[22]
|
Zhu, Q., Liang, Y., Fan, Z., Liu, Y., Zhou, C., Zhang, H., He, L., Li, T., Yang, J., Zhou, Y., Wang, J. and Wang, L. (2022) Development and Validation of a Novel Survival Prediction Model for Newly Diagnosed Lower-Grade Gliomas. Neurosurgical Focus, 52, E13. https://doi.org/10.3171/2022.1.FOCUS21596
|
[23]
|
Schwartz, L.H., Litière, S., de Vries, E., Ford, R., Gwyther, S., Man-drekar, S., Shankar, L., Bogaerts, J., Chen, A., Dancey, J., Hayes, W., Hodi, F.S., Hoekstra, O.S., Huang, E.P., Lin, N., Liu, Y., Therasse, P., Wolchok, J.D. and Seymour, L. (2016) RECIST 1.1—Update and Clarification: From the RECIST Committee. European Journal of Cancer, 62, 132-137. https://doi.org/10.1016/j.ejca.2016.03.081
|
[24]
|
Lin, J., Yin, M., Liu, L., Gao, J., Yu, C., Liu, X., Xu, C. and Zhu, J. (2022) The Development of a Prediction Model Based on Random Survival Forest for the Postoperative Prognosis of Pancreatic Cancer: A SEER-Based Study. Cancers, 14, Article 4667. https://doi.org/10.3390/cancers14194667
|
[25]
|
Zhang, L., Huang, T., Xu, F., Li, S., Zheng, S., Lyu, J. and Yin, H. (2022) Prediction of Prognosis in Elderly Patients with Sepsis Based on Machine Learning (Random Survival Forest). BMC Emergen-cy Medicine, 22, Article No. 26.
https://doi.org/10.1186/s12873-022-00582-z
|
[26]
|
Roshanaei, G., Safari, M., Faradmal, J., Abbasi, M. and Khazaei, S. (2022) Factors Affecting the Survival of Patients with Colorectal Cancer Using Random Survival Forest. Journal of Gastroin-testinal Cancer, 53, 64-71.
https://doi.org/10.1007/s12029-020-00544-3
|
[27]
|
Gittleman, H., Sloan, A.E. and Barnholtz-Sloan, J.S. (2020) An Inde-pendently Validated Survival Nomogram for Lower-Grade Glioma. Neuro-Oncology, 22, 665-674. https://doi.org/10.1093/neuonc/noz191
|
[28]
|
Hazewinkel, A.-D., Gelderblom, H. and Fiocco, M. (2022) Prediction Models with Survival Data: A Comparison between Machine Learning and the Cox Proportional Hazards Model. Medrxiv, 1-15.
https://doi.org/10.1101/2022.03.29.22273112
|